- €116.31m
- €386.34m
- €786.44m
Brief: Guerbet: Transition From Temporary Importation To Regular Supply For Lipiodol Injection
Europe Research Roundup: Essity, Ferguson, Metro Bank
Brief: Guerbet Sees Moderate Growth In Sales In 2019
Brief: Guerbet Says OptiVantage Multi-Use Injector Is Now CE-Marked
Brief: Guerbet 9-Month Revenue Down At 581.4 Million Euros
Brief: Guerbet Sees 2018 Sales Slightly Exceeding 2017 Sales
Brief: Guerbet H1 Net Income Down At 22.4 Million Euros
Brief: New Indication Approved For Guerbet’s Lipiodol Ultra Fluid
Brief: Guerbet H1 Revenue Down At 389.6 Million Euros
Brief: Guerbet And IBM Watson Health Signs Strategic Partnership For AI In Medical Imaging
Brief: Guerbet Announces Acquisition Of A New Microsphere Technology
Brief: Guerbet Expects 2018 Revenue In-Line With 2017
Brief: Guerbet Q1 Revenue Stable At 196.5 Million Euros
Brief: Guerbet Partners With Lausanne’S CHUV And CET To Launch Clinical Study
Brief: Guerbet FY EBITDA Increased By 22.4 Percent To 130 Million Euros
Brief: Guerbet: FY Revenue At Constant Exchange Rates Increases To 812.4 Million Euros
Brief: Guerbet Announces Acquisition Of Accurate Medical Therapeutics
Brief: Guerbet Updates On MHLW Decision In Japan
Brief: Guerbet 9 months revenue up at 601.4 million euros